Research progress on the intervention effects of Chinese medicine on microRNA regulating the signaling pathway of ulcerative colitis
- VernacularTitle:中药对微小RNA调控溃疡性结肠炎相关信号通路的干预作用研究进展
- Author:
Huanying ZHONG
1
;
Lijian LIU
2
;
Jiarun WEI
1
;
Liqun LI
2
;
Chengning YANG
2
;
Chaowei ZHENG
2
;
Qi HE
1
;
Yuyan WANG
1
Author Information
1. Graduate School，Guangxi University of Chinese Medicine，Nanning 530200，China
2. Dept. Two of Spleen and Stomach Diseases，the First Affiliated Hospital of Guangxi University of Chinese Medicine，Nanning 530023，China
- Publication Type:Journal Article
- Keywords:
ulcerative colitis;
microRNA;
signaling
- From:
China Pharmacy
2023;34(17):2167-2171
- CountryChina
- Language:Chinese
-
Abstract:
Ulcerative colitis （UC） is a chronic non-specific inflammatory disease characterized by the damage of the epithelial barrier of the colon and the destruction of immune homeostasis. It has a long course， no recovery and high recurrence rate， and is recognized as a difficult digestive disease. MicroRNA （miRNA） has been confirmed to be specifically or differentially expressed in both UC patients and UC animal models， so miRNA can be used as markers for UC diagnosis or reference for treatment evaluation. TCM therapy has a definite therapeutic effect， a wide range of effects， and minimal side effects in the treatment of UC， so this article takes miRNA as the starting point and systematically elaborates on the mechanism of TCM regulating UC related signaling pathways by regulating the expression of miRNA. The results show that chlorogenic acid， Anchang decoction， and Fuyang huoxue jiedu formula can regulate the expressions of miR-155， miR-146a and miR-31-5p， etc.， thereby inhibiting signal transducer and activator of transcription （STAT） signal pathway transduction to improve UC. Limonin， ginsenoside Rh2， artesunate， etc. can inhibit nuclear factor-κB （NF-κB） signaling pathway conduction to improve UC by regulating the expressions of miR-214， miR- 155 and miR-19a， etc. Nitidine chloride， berberine， resveratrol， etc. can regulate the expressions of miR-31， miR-146a， miR- 146b， etc.， thereby inhibiting the Toll-like receptor 4 （TLR4） signaling pathway to improve UC. Mango polyphenolics， Compound qinbai granules， and Astragalus membranaceus polysaccharides can regulate the expressions of miR-126 and miR-193a-3p， thereby inhibiting the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin （PI3K/AKT/mTOR） signaling pathway to improve UC.
